These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44 related articles for article (PubMed ID: 6150716)
1. [The somatostatin infusion test for the evaluation of glucose utilization in bezafibrate medication]. Vogelberg KH; Müller HJ; Hübinger A Arzneimittelforschung; 1984; 34(9):1038-41. PubMed ID: 6150716 [TBL] [Abstract][Full Text] [Related]
2. Effect of ketone bodies on glucose production and utilization in the miniature pig. Müller MJ; Paschen U; Seitz HJ J Clin Invest; 1984 Jul; 74(1):249-61. PubMed ID: 6376544 [TBL] [Abstract][Full Text] [Related]
3. Effects of bezafibrate on insulin sensitivity and insulin secretion in non-obese Japanese type 2 diabetic patients. Taniguchi A; Fukushima M; Sakai M; Tokuyama K; Nagata I; Fukunaga A; Kishimoto H; Doi K; Yamashita Y; Matsuura T; Kitatani N; Okumura T; Nagasaka S; Nakaishi S; Nakai Y Metabolism; 2001 Apr; 50(4):477-80. PubMed ID: 11288046 [TBL] [Abstract][Full Text] [Related]
4. Glucose, insulin and somatostatin infusion for the determination of insulin resistance in liver cirrhosis. Greco AV; Rebuzzi AG; Altomonte L; Manna R; Bertoli A; Ghirlanda G Horm Metab Res; 1979 Oct; 11(10):547-9. PubMed ID: 521009 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes. Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032 [TBL] [Abstract][Full Text] [Related]
6. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate. Al-Waili N Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of insulin resistance in non-obese subjects with impaired glucose tolerance. Ratzmann KP; Witt S; Schulz B Diabete Metab; 1982 Sep; 8(3):223-8. PubMed ID: 6754494 [TBL] [Abstract][Full Text] [Related]
8. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. Pagano G; Cavallo-Perin P; Cassader M; Bruno A; Ozzello A; Masciola P; Dall'omo AM; Imbimbo B J Clin Invest; 1983 Nov; 72(5):1814-20. PubMed ID: 6355186 [TBL] [Abstract][Full Text] [Related]
9. Subcutaneous microdialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus. Rajamand N; Ungerstedt U; Brismar K Diabetes Obes Metab; 2005 Sep; 7(5):525-35. PubMed ID: 16050945 [TBL] [Abstract][Full Text] [Related]
10. Effect of atorvastatin (10 mg/day) on glucose metabolism in patients with the metabolic syndrome. Huptas S; Geiss HC; Otto C; Parhofer KG Am J Cardiol; 2006 Jul; 98(1):66-9. PubMed ID: 16784923 [TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease. Tenenbaum A; Motro M; Fisman EZ; Schwammenthal E; Adler Y; Goldenberg I; Leor J; Boyko V; Mandelzweig L; Behar S Circulation; 2004 May; 109(18):2197-202. PubMed ID: 15123532 [TBL] [Abstract][Full Text] [Related]
12. Physiologic modeling of the intravenous glucose tolerance test in type 2 diabetes: a new approach to the insulin compartment. Ward GM; Walters JM; Barton J; Alford FP; Boston RC Metabolism; 2001 May; 50(5):512-9. PubMed ID: 11319711 [TBL] [Abstract][Full Text] [Related]
13. Glucose resistance contributes to diabetes mellitus in cirrhosis. Petrides AS; Schulze-Berge D; Vogt C; Matthews DE; Strohmeyer G Hepatology; 1993 Aug; 18(2):284-91. PubMed ID: 8340056 [TBL] [Abstract][Full Text] [Related]
14. [Effects of bezafibrate in the diet of hypertensive patients with dyslipidemia and hyperfibrinogenemia]. Vázquez-Chávez C; Salinas-Orozco S; Gómez-Díaz RA; Rosso-Juárez MM; Moreno-Vázquez K; Nissen-Torres T; Argüero-Sánchez R Rev Invest Clin; 1998; 50(6):491-6. PubMed ID: 10070221 [TBL] [Abstract][Full Text] [Related]
15. Patients with malnutrition related diabetes mellitus are as insulin sensitive as insulin dependent diabetics. Garg MK; Tripathy D; Shah P J Assoc Physicians India; 1999 Dec; 47(12):1145-8. PubMed ID: 11225212 [TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients. Miyazaki Y; DeFronzo RA Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983 [TBL] [Abstract][Full Text] [Related]
17. Effect of somatostatin on plasma C-peptide immunoreactivity in normal man. Canivet J; Brisson C; Gauvillé C Diabete Metab; 1977 Jun; 3(2):109-12. PubMed ID: 892126 [TBL] [Abstract][Full Text] [Related]
18. Effect of simultaneous infusion of a somatostatin analogue, insulin and glucose on serum triglycerides and blood glucose levels in man. Fukushima H; Maeda H; Suzaki K; Shimada M; Sakakida M; Kishikawa H; Nakamura N; Uzawa H Endocrinol Jpn; 1985 Apr; 32(2):241-8. PubMed ID: 2864241 [TBL] [Abstract][Full Text] [Related]